Mechanisms of arterial calcifications and consequences for cardiovascular function

Kidney International Supplements

Volumn 3, Issue 5, 2013, Pages 442-445

  London, Gérard M ^a  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Aging; Arterial calcifications; Arterial stiffness; Arteriosclerosis; Chronic renal disease

Indexed keywords

AGING; ARTERY CALCIFICATION; ARTERY DISEASE; BONE DISEASE; BONE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HUMAN; MINERAL METABOLISM; OSSIFICATION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

EID: 84896698667     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2013.92     Document Type: Review

References (66)

1. Briet M, Boutouyrie P, Laurent S et al. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 82: 383-400.
2. London GM, Drüeke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-1695.
3. Blacher J, Guérin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
4. Goodman WG, Goldin J, Kuizon BD et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. New Engl J Med 2000; 342: 1478-1483.
5. Guérin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021.
6. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757.
7. Wilson PWF, Kauppila LI, O'Donnell CJ et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103: 1529-1534.
8. London GM, Guérin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740.
9. O'Rourke MF. Mechanical principles in arterial disease. Hypertension 1995; 26: 2-9.
10. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200-204.
11. Demer LL, Tintut Y. Vascular calcification: pathobiology of multifaceted disease. Circulation 2008; 117: 2938-2948.
12. Schoppet M, Shroff RC, Hofbauer LC et al. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008; 73: 384-390.
13. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification. Lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006; 26: 1423-1430.
14. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010; 7: 528-536.
15. Neven E, De Schutter TM, De Broe ME et al. Cell biological and physicochemical aspects of arterial calcification. Kidney Int 2011; 79: 1166-1177.
16. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
17. Demer L, Tintut Y. The role of lipid oxidation products and receptor activator of nuclear factor-kB signaling in atherosclerotic calcification. Circ Res 2011; 108: 1482-1493.
18. Mody N, Parhami F, Sarafian TA et al. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-519.
19. Tanikawa T, Okaya Y, Tanikawa R et al. Advanced glycation endproducts induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK and upregulation of Runx2. J Vasc Res 2009; 46: 572-580.
20. Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25- dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18: 2116-2124.
21. Jaffe IZ, Tintut Y, Newfell BG et al. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 2007; 27: 799-805.
22. Burton DG, Matsubara H, Ikeda K. Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp Gerontol 2010; 45: 819-824.
23. Nakano-Kurimoto R, Ikeda K, Uraoka M et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating osteoblastic transition. Am J Physiol Heart Circ Physiol 2009; 297: H1673-H1684.
24. Liu Y, Drozdov I, Shroff R et al. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence associated secretory phenotype in vascular smooth muscle cells. Circ Res 2013; 112: e99-e109.
25. Doherty TM, Asotra K, Fitzpatrick LA et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 2003; 100: 11201-11206.
26. Shao JS, Sadhu J, Towler DA. Inflammation and the osteogenic regulation of vascular calcification. A review and perspective. Hypertension 2010; 55: 579-592.
27. Byon CH, Sun Y, Chen J et al. Runx2-upregulated receptor activator of nuclear factor kB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler Thromb Vasc Biol 2011; 31: 1387-1396.
28. Panizo S, Cardus A, Encinas M et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4 dependent pathway. Circ Res 2009; 104: 1041-1048.
29. Aikawa E, Nahrendor Mf, Figueiredo J-L et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imagingin vivo. Circulation 2007; 116: 2841-2850.
30. Bostrom KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011; 109: 564-577.
31. Shao J-S, Cheng S-L, Joyce M et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005; 115: 1210-1220.
32. Al-Aly Z, Shao J-S, Lai C-F et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-a-dependent signals in diabetic Ldlr mice. Arterioscler thromb Vasc Biol 2007; 27: 2589-2596.
33. Aikawa E, Aikawa M, Libby P et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin deficiency in chronic renal disease. Circulation 2009; 119: 1785-1794.
34. Tistra JS, Robinson AR, Wang L et al. NF-kB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest 2012; 122: 2601-2612.
35. Ragnauth CD, Warren DT, Yiwen Liu Y et al. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010; 121: 2200-2210.
36. Carrero JJ, Stenvinkel P, Fellström B et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302-312.
37. Shanahan C, Crouthamel MH, Kapustin A et al. Arterial calcification in chronic kidney disease: key role for calcium and phosphate. Circ Res 2011; 109: 697-711.
38. Zhao M-M, Xu M-J, Cai Y et al. Mitochondrial reactive oxygen species promote p65nuclear translocation mediating high-phosphate induced vascular calcification in vitro and in vivo. Kidney Int 2011; 79: 1071-1079.
39. Moe SM, Duan D, Doehle BP et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011.
40. Schoppet M, Shroff RC, Hofbauer LC et al. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008; 73: 384-390.
41. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
42. Sweatt A, Sane DC, Hutson SM et al. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003; 1: 178-185.
43. Price PA, June HH, Buckley JR et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001; 21: 1610-1616.
44. Schafer C, Heiss A, Schwarz A et al. The serum protein alpha 2- Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366.
45. Lomashvili K, Cobbs S, Hennigar RA et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401.
46. Huang JC, Sakata T, Pfleger LL et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004; 19: 234-244.
47. Shao JS, Cheng SL, Charlton-Kachigian N et al. Teriparatide [human parathyroid hormone-(1-34)] inhibits osteogenic vascular calcification in diabetes low density lipoprotein receptor-deficient mice. J Biol Chem 2003; 278: 50195-50200.
48. Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008; 389: 233-241.
49. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
50. Lim K, Lu T-S, Molostvov G et al. Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012; 125: 2243-2255.
51. Huang H, Virmani R, Younis H et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001; 103: 1051-1056.
52. Lin TC, Tintut Y, Lyman A et al. Mechanical response of a calcified plaque model to fluid shear force. Ann Biomed Eng 2006; 34: 1535-1541.
53. Kono K, Fujii H, Nakai K et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012; 82: 344-351.
54. O'Neil WC, Lomashvili KA, Malluche HH et al. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 2011; 79: 512-517.
55. Helas S, Goettsch C, Schoppet M et al. Inhibition of receptor activator of NF-B ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 2009; 175: 473-478.
56. Price PA, Roublick AM, Wiliamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
57. Osako MK, Nakagami H, Koibuchi N et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 2010; 107: 466-475.
58. Kawata T, Nagano N, Obi M et al. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int 2008; 74: 1270-1277.
59. Ng K, Hildreth C, Avolio AP et al. Angiotensin-converting enzyme inhibitor limits model of cystic renal disease pulse-wave velocity and aortic calcification in a rat. Am J Physiol Renal Physiol 2011; 301: F959-F966.
60. Voelkl J, Alesutan L, Leibrock CB et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 2013; 123: 812-822.
61. Derwall M, Malhotra R, Lai CS et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 613-622.
62. Chertow GM, Burke SK, Raggi P et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patient. Kidney Int 2002; 62: 245-252.
63. London GM, Marchais SJ, Guérin AP et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
64. The EVOLVE trial Investigators. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 2012; 367: 2482-2494.
65. Schlieper G, Westenfeld R, Krüger T et al. Circulating nonphosphorylated carboxylated matrix GLA protein predicts survival in ESRD. J Am Soc Nephrol 2011; 22: 387-395.
66. Westenfeld R, Krüger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialyzed patients: a random trial. Am J Kidney Dis 2012; 59: 186-195.